Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$146.14 0.68 (0.46%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 384.35(B)
Last Volume: 6,182,604 Avg Vol: 8,314,942
52 Week Range: $144.45 - $174.48
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  21
Guru Rank Value     : 20.3
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 68,288 68,288 115,451 522,170
Total Sell Value $10,723,734 $10,723,734 $18,652,688 $88,845,171
Total People Sold 2 2 5 10
Total Sell Transactions 2 2 5 24
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 606
  Page 2 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-12 4 D $157.40 $1,104,791 D/D (7,019) 111,625     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 14,960 118,644     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-12 4 D $157.40 $82,320 D/D (523) 18,746     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 1,912 19,269     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-12 4 D $157.40 $336,206 D/D (2,136) 23,735     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-12 4 A $0.00 $0 D/D 790 25,871     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 4,701 25,081     -
   Hait William See Remarks   •       •      –    2024-02-12 4 D $157.40 $641,562 D/D (4,076) 38,240     -
   Hait William See Remarks   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 8,932 42,316     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-12 4 D $157.40 $2,502,660 D/D (15,900) 361,339     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 36,618 377,239     -
   Swanson James D. EVP, CIO   •       •      –    2024-02-12 4 D $157.40 $266,793 D/D (1,695) 14,318     -
   Swanson James D. EVP, CIO   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 5,456 16,013     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-12 4 D $157.40 $1,702,438 D/D (10,816) 67,883     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 25,835 78,699     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       •      –    2024-02-12 4 D $157.40 $2,109,632 D/D (13,403) 154,215     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 26,202 167,618     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-12 4 D $157.40 $1,112,188 D/D (7,066) 81,948     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 13,813 89,014     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-12 4 D $157.40 $162,752 D/D (1,034) 7,925     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 2,859 8,959     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-09 4 D $156.76 $4,284,721 D/D (27,333) 75,201     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-09 4 OE $90.44 $3,223,101 D/D 35,638 102,534     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-09 4 D $156.76 $15,466,255 D/D (98,662) 340,621     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-09 4 OE $90.44 $11,844,836 D/D 130,969 439,283     -
  606 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us